mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.04 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.05 |
mRNA |
SU11274 |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.05 |
mRNA |
XL765 |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.05 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.05 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.05 |
mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.06 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.06 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.06 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.06 |